Scholarlink

Background <p>Post-therapy assessment of paraskeletal plasmacytoma (PM) in multiple myeloma (MM) relies on lesion persistence and/or size changes on whole-body low-dose CT (WBLDCT).</p> Purpose <p>To evaluate the prognostic value of WBLDCT and <sup>18</sup>F-FDG-PET/CT (PET/CT) before and after therapy in newly diagnosed MM patients with PM, and a small subgroup with solitary plasmacytoma (PSO), aiming to refine future imaging response criteria.</p> Methods <p>We retrospectively reviewed PET/CT and WBLDCT images of 42 patients (39 MM, 3 PSO) undergoing first-line therapy from October 27, 2016, to June 12, 2021. Imaging including criteria were a positive PET/CT scan at baseline and a subsequent negative PET/CT scan prior to starting maintenance. Negative PET/CT was defined applying Deauville criteria for focal, PM, and bone marrow uptake, with complete metabolic response defined as uptake below liver background (Deauville scores &lt; 4). PET parameters (IMPeTUs criteria), CT morphological/technical features, and baseline laboratory data were assessed using univariate and multivariate analyses for their impact on clinical outcomes.</p> Results <p>Pre-maintenance SUVmax of the PM lesions predicted adverse progression-free survival (PFS) and Deauville Score 3 identified patients with significantly worse PFS (median 27 months vs. not reached; HR = 3.45, <i>p</i> = 0.05) and showed a trend toward inferior overall survival (OS) (52 months vs. not reached; HR = 2.99, <i>p</i> = 0.16), remaining an independent prognostic factor. In transplanted patients (<i>n</i> = 32), PM Deauville Score 3 predicted inferior PFS (median 27 vs. 74 months, <i>p</i> = 0.015) and OS (39 months vs. not reached, <i>p</i> = 0.03). CT had limited prognostic value, except for pre-maintenance transverse diameter (PFS: HR = 1.86, <i>p</i> = 0.02) and absence of cortical bone regeneration.</p> Conclusions <p>Pre-maintenance PM Deauville Score 3 has been shown to be representative of adverse outcomes, highlighting the added prognostic value of 18F-FDG-PET/CT over WBLDCT alone, and the possibility of refining future PET monitoring in this patient population.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Paraskeletal disease in multiple myeloma after treatment: is there a possible prognostic role of whole-body low dose CT (WBLDCT) vs. 18 F-FDG-PET/CT?

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月19日

查看全文
  • Davide Bezzi,
  • Elena Zamagni,
  • Martina Di Franco,
  • Marco Talarico,
  • Vincenza Solli,
  • Katia Mancuso,
  • Simona Barbato,
  • Arrigo Cattabriga,
  • Stefano Brocchi,
  • Cristina Mosconi,
  • Cristina Nanni

摘要

Background

Post-therapy assessment of paraskeletal plasmacytoma (PM) in multiple myeloma (MM) relies on lesion persistence and/or size changes on whole-body low-dose CT (WBLDCT).

Purpose

To evaluate the prognostic value of WBLDCT and 18F-FDG-PET/CT (PET/CT) before and after therapy in newly diagnosed MM patients with PM, and a small subgroup with solitary plasmacytoma (PSO), aiming to refine future imaging response criteria.

Methods

We retrospectively reviewed PET/CT and WBLDCT images of 42 patients (39 MM, 3 PSO) undergoing first-line therapy from October 27, 2016, to June 12, 2021. Imaging including criteria were a positive PET/CT scan at baseline and a subsequent negative PET/CT scan prior to starting maintenance. Negative PET/CT was defined applying Deauville criteria for focal, PM, and bone marrow uptake, with complete metabolic response defined as uptake below liver background (Deauville scores < 4). PET parameters (IMPeTUs criteria), CT morphological/technical features, and baseline laboratory data were assessed using univariate and multivariate analyses for their impact on clinical outcomes.

Results

Pre-maintenance SUVmax of the PM lesions predicted adverse progression-free survival (PFS) and Deauville Score 3 identified patients with significantly worse PFS (median 27 months vs. not reached; HR = 3.45, p = 0.05) and showed a trend toward inferior overall survival (OS) (52 months vs. not reached; HR = 2.99, p = 0.16), remaining an independent prognostic factor. In transplanted patients (n = 32), PM Deauville Score 3 predicted inferior PFS (median 27 vs. 74 months, p = 0.015) and OS (39 months vs. not reached, p = 0.03). CT had limited prognostic value, except for pre-maintenance transverse diameter (PFS: HR = 1.86, p = 0.02) and absence of cortical bone regeneration.

Conclusions

Pre-maintenance PM Deauville Score 3 has been shown to be representative of adverse outcomes, highlighting the added prognostic value of 18F-FDG-PET/CT over WBLDCT alone, and the possibility of refining future PET monitoring in this patient population.